Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers
- 30 April 2001
- journal article
- clinical trial
- Published by Elsevier BV in Vaccine
- Vol. 19 (23-24), 3179-3188
- https://doi.org/10.1016/s0264-410x(01)00020-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Live attenuated tetravalent dengue vaccineVaccine, 2000
- Dengue and dengue haemorrhagic feverThe Lancet, 1998
- Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteersVaccine, 1996
- A Live Attenuated Dengue-L Vaccine Candidate (45AZ5) Passaged In Primary Dog Kidney Cell Culture Is Attenuated And Immunogenic For HumansThe Journal of Infectious Diseases, 1994
- Dengue: the risk to developed and developing countries.Proceedings of the National Academy of Sciences of the United States of America, 1994
- In vitro homotypic and heterotypic interference by defective interfering particles of West Nile virusJournal of General Virology, 1991
- STUDY OF BIVALENT DENGUE VACCINE IN VOLUNTEERSThe Lancet, 1989
- Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.JCI Insight, 1989
- RANDOMISED TRIAL OF ALTERNATIVE FORMULATIONS OF ORAL POLIOVACCINE IN BRAZILThe Lancet, 1988
- Dengue 2 Vaccine: Dose Response in Volunteers in Relation to Yellow Fever Immune StatusThe Journal of Infectious Diseases, 1983